Ursula Ehmer

2.7k total citations
52 papers, 1.6k citations indexed

About

Ursula Ehmer is a scholar working on Hepatology, Molecular Biology and Oncology. According to data from OpenAlex, Ursula Ehmer has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 16 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Ursula Ehmer's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Neonatal Health and Biochemistry (8 papers) and Liver Disease and Transplantation (6 papers). Ursula Ehmer is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Neonatal Health and Biochemistry (8 papers) and Liver Disease and Transplantation (6 papers). Ursula Ehmer collaborates with scholars based in Germany, United States and Italy. Ursula Ehmer's co-authors include Christian P. Strassburg, Michael P. Manns, Julien Sage, Sandra Kalthoff, N Freiberg, Arndt Vogel, Patrick Viatour, Tim O. Lankisch, Thomas Erichsen and Anne‐Flore Zmoos and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Ursula Ehmer

48 papers receiving 1.6k citations

Peers

Ursula Ehmer
Dick Knook Netherlands
Mieko Iwahashi United States
Bharat Bhushan United States
Wei An China
Bettina G. Papouchado United States
Ursula Ehmer
Citations per year, relative to Ursula Ehmer Ursula Ehmer (= 1×) peers Wen‐Lung Ma

Countries citing papers authored by Ursula Ehmer

Since Specialization
Citations

This map shows the geographic impact of Ursula Ehmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula Ehmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula Ehmer more than expected).

Fields of papers citing papers by Ursula Ehmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ursula Ehmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula Ehmer. The network helps show where Ursula Ehmer may publish in the future.

Co-authorship network of co-authors of Ursula Ehmer

This figure shows the co-authorship network connecting the top 25 collaborators of Ursula Ehmer. A scholar is included among the top collaborators of Ursula Ehmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ursula Ehmer. Ursula Ehmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khaled, Najib Ben, Julia Schneider, Alexander Weich, et al.. (2025). Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real‐World Analysis of the IMMUreal Cohort. Alimentary Pharmacology & Therapeutics. 61(11). 1755–1766. 1 indexed citations
2.
Berger, Moritz, Farsaneh Sadeghlar, Christoph Roderburg, et al.. (2024). 191P Evaluating sorafenib as second-line treatment for advanced hepatocellular carcinoma: SORA-2, an European retrospective multicenter study. Annals of Oncology. 35. S86–S86.
3.
Bauer, Ulrike, et al.. (2024). Decreased overall survival in patients with hepatocellular carcinoma during the COVID-19 pandemic. Translational Gastroenterology and Hepatology. 10. 9–9.
4.
Koliogiannis, Dionysios, Markus Bo Schoenberg, Dominik Koch, et al.. (2023). Frequent Follow-Up of Delisted Liver Transplant Candidates Is Necessary: An Observational Study about Characteristics and Outcomes of Delisted Liver Transplant Candidates. Journal of Clinical Medicine. 12(18). 5880–5880. 1 indexed citations
5.
Nadjiri, Jonathan, Tobias Waggershauser, Ursula Ehmer, et al.. (2023). Transjugular intrahepatic portosystemic shunt creation (TIPS) in the angio-CT—a hybrid intervention with image fusion. European Radiology. 33(11). 7380–7387. 2 indexed citations
6.
Mogler, Carolin, Silke Wunderlich, Maximilian Reichert, et al.. (2023). Fulminant Liver Failure after Treatment with a Checkpoint Inhibitor for Gastric Cancer: A Case Report and Review of the Literature. Journal of Clinical Medicine. 12(14). 4641–4641. 3 indexed citations
7.
Bauer, Ulrike, et al.. (2022). Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature. Clinical Journal of Gastroenterology. 15(6). 1124–1129. 7 indexed citations
10.
Bauer, Ulrike, Carolin Mogler, Rickmer Braren, et al.. (2019). Progression after Immunotherapy for Fibrolamellar Carcinoma. Visceral Medicine. 35(1). 39–42. 15 indexed citations
11.
Moleirinho, Susana, Sany Hoxha, Vinay Mandati, et al.. (2017). Regulation of localization and function of the transcriptional co-activator YAP by angiomotin. eLife. 6. 69 indexed citations
12.
Lahmer, Tobias, Marlena Messer, Ursula Ehmer, et al.. (2015). Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS. Mycopathologia. 181(3-4). 267–271. 3 indexed citations
13.
Ehmer, Ursula, et al.. (2011). RB deletion disrupts coordination between DNA replication licensing and mitotic entry in vivo. Molecular Biology of the Cell. 22(7). 931–939. 14 indexed citations
14.
Erichsen, Thomas, et al.. (2010). Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids. Journal of Hepatology. 52(4). 570–578. 37 indexed citations
15.
Kalthoff, Sandra, Ursula Ehmer, N Freiberg, Michael P. Manns, & Christian P. Strassburg. (2010). Coffee Induces Expression of Glucuronosyltransferases by the Aryl Hydrocarbon Receptor and Nrf2 in Liver and Stomach. Gastroenterology. 139(5). 1699–1710.e2. 94 indexed citations
16.
Lankisch, Tim O., Georg M. N. Behrens, Ursula Ehmer, et al.. (2009). Gilbert’s syndrome and hyperbilirubinemia in protease inhibitor therapy – An extended haplotype of genetic variants increases risk in indinavir treatment. Journal of Hepatology. 50(5). 1010–1018. 30 indexed citations
17.
Strassburg, Christian P., Sandra Kalthoff, & Ursula Ehmer. (2008). Variability and Function of Family 1 Uridine-5′-Diphosphate Glucuronosyltransferases (UGT1A). Critical Reviews in Clinical Laboratory Sciences. 45(6). 485–530. 48 indexed citations
18.
Lankisch, Tim O., Thomas Erichsen, Ursula Ehmer, et al.. (2008). Aryl hydrocarbon receptor-mediated regulation of the human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene. Archives of Toxicology. 82(9). 573–582. 33 indexed citations
19.
Strassburg, Christian P., Tim O. Lankisch, Michael P. Manns, & Ursula Ehmer. (2008). Family 1 uridine-5′-diphosphate glucuronosyltransferases (UGT1A): from Gilbert’s syndrome to genetic organization and variability. Archives of Toxicology. 82(7). 415–433. 33 indexed citations
20.
Ehmer, Ursula, et al.. (2004). Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology. 39(4). 970–977. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026